HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Electronic Letters to:

Molecular Diagnostics and Genetics: Donald H. Chace, James C. DiPerna, Brenda L. Mitchell, Bethany Sgroi, Lindsay F. Hofman, and Edwin W. Naylor Electrospray Tandem Mass Spectrometry for Analysis of Acylcarnitines in Dried Postmortem Blood Specimens Collected at Autopsy from Infants with Unexplained Cause of Death Clin Chem 2001; 47: 1166-1182 [Abstract] [Full text] [PDF]

eLetters: Submit a response to this article

Electronic letters published:

Clarification

Donald Chace   (13 July 2001)

Clarification 13 July 2001
Donald Chace, Section Chief Neo Gen Screening Send letter to journal: Re: Clarification dhchace{at}neogenscreening.com Donald Chace	It has come to my attention that one sentence in Paragraph 4 in the introduction of this document needs clarification. Please replace this following sentence Using statistics from the CDC (31) that 3 880 894 infants were born in the US in 1997, we can approximate that 465 infants will be born per year with a metabolic disorder detectable by MS/MS. with the sentence Using statistics from the CDC (31) that 3 880 894 infants were born in the US in 1997, we can approximate that 465 infants will be born per year with a metabolic disorder detectable from an acylcarnitine profile by MS/MS.